Founded in February 2015, AntalGenics is located in the Scientific Park of the University Miguel Hernández in Elche, Alicante, Spain. It is a biotechnological company focused on the discovery and development of new bioactive molecules for biomedical and dermocosmetic applications by modulating the neurosensory system. Its staff has expertise in inflammatory peripheral nerve excitability and skin physiopathology, modulation of targets located in the peripheral nervous system form skin, design and efficacy assessment of drugs in the development phase using a wide range of methods on skin cells and sensory neurons and in in vitro preclinical assays.
Angelini is an international pharmaceutical group founded in Italy in the early 20th century, leader in the healthcare, and with direct presence in 20 countries and a worldwide distribution network. The Pharma sector is the Company core business accounting for about half of the total turnover, and including activities in the research, development, manufacturing and marketing of active principles, medicines, cosmetics, medical devices and food supplements.
The innovation activities are implemented in the RR&D (Research, Regulatory & Development), also through scientific networking and public-private partnerships worldwide, strongly recognizing their relevance as source of innovation to simultaneously go beyond the frontiers of the knowledge and pursue the economic growth.
In collaboration with
- COSMETICA ITALIA – The Italian personal care association
Apharm is an Italian company, founded in 2005, that develops and sells pharmaceutical products (medical devices, cosmetics and food supplements). Its business is also focused on the use of hyaluronic acid in various formulas for different clinical conditions. Apharm has recently entered a new field of application, aesthetic medicine, creating a specific, dedicated line in Italy.
Founded in 2008 and located in Novara, Italy, within a chemical-pharmaceutical technology park shared with the University (faculty of Chemistry and Pharmacy), public and private research companies. Chemelectiva is mainly focusing on the research and development of innovative processes for the production of Active Pharmaceutical Ingredients (API) as well as Finished Dosage Forms (FDF) both for ethical and generic worldwide market including cosmetics. The innovation activities are also related to the design of new molecules as active ingredients for both pharmaceutical and cosmetics. More than 40 international patents applications were filed and more than 10 active products manufactured worldwide based on technologies developed by Chemelectiva.
Last modified: March 14, 2019